title: Unusual macular degeneration following breast cancer.
authors.affiliation: Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
authors.forename: Ron
authors.initials: R
authors.lastname: Margolis
authors.forename: G Thomas
authors.initials: GT
authors.lastname: Budd
authors.forename: Arun D
authors.initials: AD
authors.lastname: Singh
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary*; D000077384:Anastrozole; D047072:Aromatase Inhibitors / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D002830:Choroid Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary*; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008268:Macular Degeneration / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D015409:Mastectomy, Radical; D008875:Middle Aged; D009570:Nitriles / Q000627:therapeutic use; D013667:Technetium; D014057:Tomography, X-Ray Computed; D014230:Triazoles / Q000627:therapeutic use
chemical_list: D047072:Aromatase Inhibitors; D009570:Nitriles; D014230:Triazoles; D000077384:Anastrozole; D013667:Technetium